Cargando…
A novel rabies vaccine based on infectious propagating particles derived from hybrid VEEV-Rabies replicon
BACKGROUND: Live attenuated vaccines (LAVs) can mimic natural infection and have advantages to stimulate a robust and sustained immune response as well as to confer long-term protection. However, safety concerns is one of the major obstacles for LAVs development. In an effort to achieve the optimal...
Autores principales: | Zhang, Ya-Nan, Chen, Chen, Deng, Cheng-Lin, Zhang, Cheng-guang, Li, Na, Wang, Zhen, Zhao, Ling, Zhang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273168/ https://www.ncbi.nlm.nih.gov/pubmed/32512518 http://dx.doi.org/10.1016/j.ebiom.2020.102819 |
Ejemplares similares
-
A new screening system for entry inhibitors based on cell-to-cell transmitted syncytia formation mediated by self-propagating hybrid VEEV-SARS-CoV-2 replicon
por: Li, Na, et al.
Publicado: (2022) -
Human Rabies in China
por: Zhang, Yong-Zhen, et al.
Publicado: (2005) -
PROPAGATION OF RABIES VIRUS IN TISSUE CULTURE
por: Webster, Leslie T., et al.
Publicado: (1937) -
Infectious Diseases and Vaccination for Rabies
por: Pasteur, M.
Publicado: (1884) -
Recombinant rabies virus with the glycoprotein fused with a DC-binding peptide is an efficacious rabies vaccine
por: Zhang, Yachun, et al.
Publicado: (2017)